Logo image of SAGE.CA

SAGE POTASH CORP (SAGE.CA) Stock Fundamental Analysis

TSX-V:SAGE - CA78667T1066 - Common Stock

0.42 CAD
+0.02 (+5%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

0

Overall SAGE gets a fundamental rating of 0 out of 10. We evaluated SAGE against 0 industry peers in the Unkown industry. SAGE has a bad profitability rating. Also its financial health evaluation is rather negative. SAGE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SAGE had negative earnings in the past year.
In the past year SAGE has reported a negative cash flow from operations.
SAGE.CA Yearly Net Income VS EBIT VS OCF VS FCFSAGE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -150.83%
ROE -1570.96%
ROIC N/A
ROA(3y)-165.99%
ROA(5y)N/A
ROE(3y)-1157.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SAGE.CA Yearly ROA, ROE, ROICSAGE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -500 -1K -1.5K

1.3 Margins

SAGE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SAGE.CA Yearly Profit, Operating, Gross MarginsSAGE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for SAGE has been increased compared to 1 year ago.
The debt/assets ratio for SAGE is higher compared to a year ago.
SAGE.CA Yearly Shares OutstandingSAGE.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 20M 40M 60M 80M
SAGE.CA Yearly Total Debt VS Total AssetsSAGE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -1.19, we must say that SAGE is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 1.94 is on the high side and indicates that SAGE has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Altman-Z -1.19
ROIC/WACCN/A
WACCN/A
SAGE.CA Yearly LT Debt VS Equity VS FCFSAGE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 1M -1M 2M -2M -3M

2.3 Liquidity

SAGE has a Current Ratio of 0.35. This is a bad value and indicates that SAGE is not financially healthy enough and could expect problems in meeting its short term obligations.
SAGE has a Quick Ratio of 0.35. This is a bad value and indicates that SAGE is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
SAGE.CA Yearly Current Assets VS Current LiabilitesSAGE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

SAGE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.62%.
EPS 1Y (TTM)2.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-330%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SAGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SAGE.CA Price Earnings VS Forward Price EarningsSAGE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAGE.CA Per share dataSAGE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SAGE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAGE POTASH CORP

TSX-V:SAGE (9/5/2025, 7:00:00 PM)

0.42

+0.02 (+5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap44.36M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 142.68
P/tB 142.68
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -150.83%
ROE -1570.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-165.99%
ROA(5y)N/A
ROE(3y)-1157.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 238.77%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -1.19
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1418.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-330%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.52%
OCF growth 3YN/A
OCF growth 5YN/A